+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pet Diabetes Care - Global Strategic Business Report

  • PDF Icon

    Report

  • 369 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6068955
The global market for Pet Diabetes Care was valued at US$1.8 Billion in 2025 and is projected to reach US$3.2 Billion by 2032, growing at a CAGR of 8.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Pet Diabetes Care Market - Key Trends & Drivers Summarized

What Is Pet Diabetes Care and Why Is It Important?

Pet diabetes care refers to the range of treatments, monitoring tools, and management practices designed to help pets diagnosed with diabetes manage their condition effectively. Just like in humans, diabetes in pets is a serious condition where the body either cannot produce enough insulin or becomes resistant to insulin, leading to elevated blood sugar levels. The most common form of diabetes in pets, especially in dogs and cats, is diabetes mellitus. Managing this condition involves a combination of proper diet, insulin therapy, regular monitoring of blood sugar levels, and maintaining a healthy lifestyle.

Pet diabetes care is crucial because untreated diabetes can lead to severe health complications such as kidney failure, blindness, or nerve damage, which may significantly impact a pet's quality of life. The management of the disease typically includes administering insulin injections, regulating the pet's diet to maintain stable glucose levels, and regular veterinary check-ups to monitor the progression of the disease. With proper care and treatment, pets with diabetes can lead long, healthy lives. As the prevalence of pet diabetes rises, both pet owners and veterinarians are turning to specialized products and services to help manage the disease effectively, contributing to the expansion of the pet diabetes care market.

Why Is the Pet Diabetes Care Market Expanding?

The pet diabetes care market is expanding due to several key factors, including the increasing prevalence of diabetes in pets, the growing awareness among pet owners about diabetes management, and advancements in veterinary care and technology. One of the major drivers of growth is the rising number of pets diagnosed with diabetes. According to veterinary studies, obesity, poor diet, and genetics are leading causes of diabetes in pets, particularly in older cats and dogs. As pets become more overweight or sedentary, the likelihood of developing diabetes increases. As a result, veterinarians are diagnosing diabetes more frequently, driving the demand for specialized products and care for managing the condition.

The increasing awareness of diabetes in pets is also contributing to market growth. Many pet owners are becoming more aware of the signs of diabetes, such as excessive thirst, urination, weight loss, and lethargy, leading to earlier diagnosis and treatment. This increased knowledge is driving demand for diabetes care products such as insulin, syringes, glucose meters, and specialized diabetic pet food. Furthermore, as pet owners increasingly view their animals as family members, there is a growing commitment to providing high-quality care to pets with diabetes, ensuring they live healthier, more comfortable lives.

Advancements in veterinary care, including improved diagnostic tools and better insulin treatments, are another factor driving the market. New types of insulin are more effective in controlling blood sugar levels in pets, while the development of glucose monitoring devices has made it easier for pet owners to track their pet's blood sugar levels at home. This enables more precise and proactive management of the disease. Veterinary practices are also adopting more personalized treatment approaches based on the individual needs of pets, which is further fueling the demand for specialized diabetes care products and services.

What Key Trends Are Shaping the Future of Pet Diabetes Care?

Several key trends are shaping the future of the pet diabetes care market, including the increasing use of technology for diabetes management, the rise of personalized and prescription diets for diabetic pets, and the growing focus on prevention. One significant trend is the growing use of technology to monitor and manage diabetes in pets. Devices such as at-home glucose meters, continuous glucose monitoring systems, and smart insulin pens are revolutionizing diabetes care for pets. These technologies enable pet owners to monitor their pets' blood glucose levels more frequently and accurately, reducing the risks associated with high or low blood sugar. Advances in telemedicine are also allowing pet owners to consult with veterinarians remotely, offering convenience and improving the ability to manage diabetes from home.

Another important trend is the increasing availability of specialized prescription diets and foods tailored to the needs of diabetic pets. These diets are formulated with the right balance of nutrients to help control blood sugar levels, providing pets with the right balance of protein, fiber, and carbohydrates to maintain healthy glucose metabolism. Prescription pet foods are becoming more widely available and are recommended by veterinarians to help manage the dietary needs of diabetic pets. As research into the nutritional requirements of diabetic animals continues to evolve, the availability of specialized diets for managing diabetes is expected to expand.

Preventative care is another key trend influencing the pet diabetes care market. As pet owners become more proactive about their pets' health, there is a growing focus on preventing diabetes before it starts. Preventative strategies include weight management programs, exercise regimens, and dietary modifications to reduce the risk of obesity, which is a major risk factor for diabetes in pets. In addition to treating pets already diagnosed with diabetes, veterinarians are increasingly emphasizing the importance of regular health check-ups, screenings, and lifestyle changes to prevent the onset of diabetes, thereby expanding the market for preventative products and services.

What Are the Key Drivers of Growth in the Pet Diabetes Care Market?

The growth in the pet diabetes care market is driven by several factors, including the increasing prevalence of pet diabetes, advancements in diabetes management technology, and the growing demand for specialized veterinary care. One of the primary drivers is the rising incidence of diabetes in pets, particularly among older animals and those with obesity or certain genetic predispositions. As pet owners become more aware of the importance of early diagnosis and treatment, the demand for diabetes-related products and services, such as insulin, glucose meters, and prescription diets, has risen. The increasing number of pet owners with pets suffering from diabetes directly contributes to the market's expansion.

Advancements in technology are another key factor driving the growth of the pet diabetes care market. New, more effective insulin treatments and continuous glucose monitoring devices have made it easier for pet owners to manage their pets' diabetes more efficiently. The development of at-home blood glucose testing kits and continuous monitoring systems allows for more accurate and frequent assessments of blood sugar levels, ensuring better control over the disease and reducing the risks of complications. This technological progress is empowering pet owners to manage diabetes more effectively, leading to a growing demand for innovative products and devices.

The increasing focus on preventative care is also contributing to the growth of the pet diabetes care market. As more pet owners become proactive in managing their pets' health, they are seeking solutions to reduce the risk of diabetes or manage early-stage symptoms. This focus on prevention includes weight management, exercise, and dietary adjustments, and is leading to a rise in the use of preventative diabetes care products, such as special foods or supplements that promote healthy glucose metabolism. The combination of advancements in technology, growing awareness about pet health, and the demand for preventative measures is driving the growth of the pet diabetes care market, with the continued evolution of products and services expected to meet the increasing needs of diabetic pets and their owners.

Report Scope

The report analyzes the Pet Diabetes Care market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Animal Type (Dogs, Cats); Solution Type (Diabetes Treatment, Glucose Monitoring Devices); Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Dogs segment, which is expected to reach US$2.4 Billion by 2032 with a CAGR of a 9.7%. The Cats segment is also set to grow at 6.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $555.1 Million in 2025, and China, forecasted to grow at an impressive 13.7% CAGR to reach $842.2 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Pet Diabetes Care Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pet Diabetes Care Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Pet Diabetes Care Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Allison Medical, Inc., ALR Technologies, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Pet Diabetes Care market report include:

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.
  • Allison Medical, Inc.
  • ALR Technologies, Inc.
  • Apotex Inc.
  • Bayer AG
  • Becton, Dickinson and Company (BD)
  • Boehringer Ingelheim Vetmedica, Inc.
  • Covetrus, Inc.
  • Eli Lilly and Company
  • Henry Schein Animal Health
  • i-SENS, Inc.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • TaiDoc Technology Corporation
  • Terumo Corporation
  • Trividia Health, Inc.
  • UltiMed, Inc.
  • Zoetis Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.
  • Allison Medical, Inc.
  • ALR Technologies, Inc.
  • Apotex Inc.
  • Bayer AG
  • Becton, Dickinson and Company (BD)
  • Boehringer Ingelheim Vetmedica, Inc.
  • Covetrus, Inc.
  • Eli Lilly and Company
  • Henry Schein Animal Health
  • i-SENS, Inc.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • TaiDoc Technology Corporation
  • Terumo Corporation
  • Trividia Health, Inc.
  • UltiMed, Inc.
  • Zoetis Inc.

Table Information